Inventiva SA (IVA) Earnings Date & Reports

A.I. Advisor

published Earnings

IVA is expected to report earnings to rise 31.83% to -63 cents per share on September 25

Q2'24

Est.

$-0.63

Q1'24

Beat

by $0.04

Q4'23

Beat

by $0.04

Q3'23

Missed

by $0.48

Q2'23

Missed

by $0.51

The last earnings report on May 21 showed earnings per share of -47 cents, beating the estimate of -51 cents. With 21.82K shares outstanding, the current market capitalization sits at 93.40M.

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a company, which engages in the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis and related diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

50 rue de Dijon

Phone

+33 380447500

Employees

123

Web

https://www.inventivapharma.com